{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T21:09:34Z","timestamp":1783458574491,"version":"3.55.0"},"reference-count":18,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T00:00:00Z","timestamp":1732924800000},"content-version":"vor","delay-in-days":58,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA280970"],"award-info":[{"award-number":["R01CA280970"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,3]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:p>The sequential multiple assignment randomized trial (SMART) is the ideal study design for the evaluation of multistage treatment regimes, which comprise sequential decision rules that recommend treatments for a patient at each of a series of decision points based on their evolving characteristics. A common goal is to compare the set of so-called embedded regimes represented in the design on the basis of a primary outcome of interest. In the study of chronic diseases and disorders, this outcome is often a time to an event, and a goal is to compare the distributions of the time-to-event outcome associated with each regime in the set. We present a general statistical framework in which we develop a logrank-type test for comparison of the survival distributions associated with regimes within a specified set based on the data from a SMART with an arbitrary number of stages that allows incorporation of covariate information to enhance efficiency and can also be used with data from an observational study. The framework provides clarification of the assumptions required to yield a principled test procedure, and the proposed test subsumes or offers an improved alternative to existing methods. We demonstrate performance of the methods in a suite of simulation studies. The methods are applied to a SMART in patients with acute promyelocytic leukemia.<\/jats:p>","DOI":"10.1093\/biomtc\/ujae139","type":"journal-article","created":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T15:44:10Z","timestamp":1734104650000},"source":"Crossref","is-referenced-by-count":3,"title":["A generalized logrank-type test for comparison of treatment regimes in sequential multiple assignment randomized trials"],"prefix":"10.1093","volume":"80","author":[{"given":"Anastasios A","family":"Tsiatis","sequence":"first","affiliation":[{"name":"Department of Statistics, North Carolina State University , Raleigh, NC 27695-8203 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9202-6341","authenticated-orcid":false,"given":"Marie","family":"Davidian","sequence":"additional","affiliation":[{"name":"Department of Statistics, North Carolina State University , Raleigh, NC 27695-8203 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,11,30]]},"reference":[{"key":"2025010313104581400_bib1","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s13142-014-0265-0","article-title":"Introduction to SMART designs for the development of adaptive interventions: with application to weight loss research","volume":"4","author":"Almirall","year":"2014","journal-title":"Translational Behavioral Medicine"},{"key":"2025010313104581400_bib2","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1080\/00031305.1992.10475921","article-title":"On generalized score tests","volume":"46","author":"Boos","year":"1992","journal-title":"The American Statistician"},{"key":"2025010313104581400_bib3","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1093\/biomet\/asn025","article-title":"Supremum weighted log-rank test and sample size for comparing two-stage adaptive treatment strategies","volume":"95","author":"Feng","year":"2008","journal-title":"Biometrika"},{"key":"2025010313104581400_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2202\/1557-4679.1000","article-title":"A weighted risk set estimator for survival distributions in two-stage randomization designs with censored survival data","volume":"1","author":"Guo","year":"2005","journal-title":"The International Journal of Biostatistics"},{"key":"2025010313104581400_bib5","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1177\/1740774514525691","article-title":"SMART designs in cancer research: Learning from the past, current limitations and looking toward the future","volume":"11","author":"Kidwell","year":"2014","journal-title":"Clinical Trials"},{"key":"2025010313104581400_bib6","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/biostatistics\/kxs042","article-title":"Weighted log-rank statistic to compare shared-path adaptive treatment strategies","volume":"14","author":"Kidwell","year":"2013","journal-title":"Biostatistics"},{"key":"2025010313104581400_bib7","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/biomet\/asr019","article-title":"Sample size formulae for two-stage randomized trials with survival outcomes","volume":"98","author":"Li","year":"2011","journal-title":"Biometrika"},{"key":"2025010313104581400_bib8","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/sim.5987","article-title":"A global logrank test for adpative treatment strategies based on observational studies","volume":"33","author":"Li","year":"2014","journal-title":"Statistics in Medicine"},{"key":"2025010313104581400_bib9","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/s41416-022-02110-z","article-title":"Use of Sequential Multiple Assignment Randomized Trials (SMARTs) in oncology: systematic review of published studies","volume":"128","author":"Lorenzoni","year":"2023","journal-title":"British Journal of Cancer"},{"key":"2025010313104581400_bib10","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.0006-341X.2002.00048.x","article-title":"Estimation of survival distributions of treatment policies in two-stage randomization designs in clinical trials","volume":"58","author":"Lunceford","year":"2002","journal-title":"Biometrics"},{"key":"2025010313104581400_bib11","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1002\/sim.2022","article-title":"An experimental design for the development of adaptive treatment strategies","volume":"24","author":"Murphy","year":"2005","journal-title":"Statistics in Medicine"},{"key":"2025010313104581400_bib12","article-title":"An introduction to adaptive interventions and SMART sesigns in education","volume-title":"NCSER 2020-001","author":"Nahum-Shani","year":"2019"},{"key":"2025010313104581400_bib13","first-page":"8","article-title":"Dynamic regime marginal structural mean models for estimation of optimal dynamic treatment regimes, Part I: main content","volume":"6","author":"Orellana","year":"2010","journal-title":"The International Journal of Biostatistics"},{"key":"2025010313104581400_bib14","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1182\/blood-2010-02-269621","article-title":"Arsenic trioxide improves event-free and overall survival for adults with acute promyelocytic leukemia: North American Leukemia Intergroup Study C9710","volume":"116","author":"Powell","year":"2010","journal-title":"Blood"},{"key":"2025010313104581400_bib15","volume-title":"Semiparametric Theory and Missing Data","author":"Tsiatis","year":"2006"},{"key":"2025010313104581400_bib16","volume-title":"Dynamic Treatment Regimes: Statistical Methods for Precision Medicine","author":"Tsiatis","year":"2020"},{"key":"2025010313104581400_bib17","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/biom.13562","article-title":"Interim monitoring in sequential multiple assignment randomized trials","volume":"79","author":"Wu","year":"2023","journal-title":"Biometrics"},{"key":"2025010313104581400_bib18","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1111\/biom.12845","article-title":"Modeling survival distribution as a function of time to treatment discontinuation: A dynamic treatment regime approach","volume":"74","author":"Yang","year":"2018","journal-title":"Biometrics"}],"container-title":["Biometrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/biometrics\/article-pdf\/80\/4\/ujae139\/61199928\/ujae139.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/biometrics\/article-pdf\/80\/4\/ujae139\/61199928\/ujae139.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T13:11:00Z","timestamp":1735909860000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/biometrics\/article\/doi\/10.1093\/biomtc\/ujae139\/7914212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,3]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,10,3]]}},"URL":"https:\/\/doi.org\/10.1093\/biomtc\/ujae139","relation":{},"ISSN":["0006-341X","1541-0420"],"issn-type":[{"value":"0006-341X","type":"print"},{"value":"1541-0420","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,12]]},"published":{"date-parts":[[2024,10,3]]},"article-number":"ujae139"}}